Cargando…

Nonalcoholic fatty liver disease is specifically related to the risk of hepatocellular cancer but not extrahepatic malignancies

OBJECTIVE: We performed a matched cohort study among individuals with and without nonalcoholic fatty liver disease (NAFLD) to determine: 1) the incidence of cancers (extrahepatic and liver) and their spectrum and 2) if NAFLD increases the risk of extrahepatic cancers. METHODS: The NAFLD and non-NAFL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albhaisi, Somaya, McClish, Donna, Kang, Le, Gal, Tamas, Sanyal, Arun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732089/ https://www.ncbi.nlm.nih.gov/pubmed/36506048 http://dx.doi.org/10.3389/fendo.2022.1037211

Ejemplares similares

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2023)

Recent advances in understanding and managing non-alcoholic fatty liver disease
por: Albhaisi, Somaya, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease in lean individuals
por: Albhaisi, Somaya, et al.
Publicado: (2019)

Current and Potential Therapies Targeting Inflammation in NASH
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
por: Li, Andrew A., et al.
Publicado: (2020)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease
por: Yi, Jiayi, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Role of extracellular vesicles in nonalcoholic fatty liver disease
por: Jiang, Wei, et al.
Publicado: (2023)

Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy
por: Huang, Chen, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease in University Rugby Football Players
por: Nirengi, Shinsuke, et al.
Publicado: (2018)

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
por: Tang, Haiying, et al.
Publicado: (2023)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
por: Zhou, Fangli, et al.
Publicado: (2021)

Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
por: Tsankof, Alexandra, et al.
Publicado: (2022)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
por: Takahashi, Hirokazu, et al.
Publicado: (2018)

Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)

Cognitive Function in Liver Transplantation
por: Albhaisi, Somaya A. M., et al.
Publicado: (2020)

Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease
por: Zhong, Fang, et al.
Publicado: (2021)

Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
por: Zhou, Xuelian, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
por: Yu, Yuetian, et al.
Publicado: (2023)

Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
por: Gonzalez, Andrea, et al.
Publicado: (2020)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuyuan, et al.
Publicado: (2022)

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
por: Venniyoor, Ajit, et al.
Publicado: (2021)

Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis
por: Liu, Shou-Sheng, et al.
Publicado: (2020)

Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index
por: Chen, Xueyu, et al.
Publicado: (2022)

Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
por: Zhao, Yanhua, et al.
Publicado: (2022)

The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
por: Ling, Qin, et al.
Publicado: (2023)

Causal effects of nonalcoholic fatty liver disease on cerebral cortical structure: a Mendelian randomization analysis
por: Mai, Zhiliang, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Inayat, Faisal, et al.
Publicado: (2016)

Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese
por: Jiang, Li-Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bohroiiijg8deghiuuc3m4a2id